068330 — Ilshinbiobase Co Share Price
- KR₩44bn
- KR₩6bn
- KR₩11bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.72 | ||
Price to Tang. Book | 0.74 | ||
Price to Free Cashflow | 10.56 | ||
Price to Sales | 4.02 | ||
EV to EBITDA | 2.33 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 3.74% | ||
Return on Equity | 6.49% | ||
Operating Margin | 20.91% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 21,035.42 | 24,378.94 | 20,433.37 | 16,437.05 | 10,817.96 | n/a | n/a | -11.24% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +5.69 | +19.2 | -24.88 | +44.34 | -38.27 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
ilShinbiobase Co., Ltd. is a Korea-based company engaged in the manufacture of freezers and freeze dryers used in biotechnology and food industries. The Company’s products include freeze dryers, which are used for drying of sera, antibiotics, enzymes, laboratory samples and foods; programmable type freeze dryers, which can control temperature, time and vacuum of free dryer systems and used in early stage of researches; deep freezers, which are used for biotechnology industry, and ice makers, which are used in research laboratories. It also provides blood bank refrigerators, pharmaceutical refrigerators, shakers, food processing equipment and others. The Company distributes its products within domestic and to overseas markets.
Directors
- Seong Dae Hong CEO (53)
- Jae Yong Kim OTH (44)
- Bang Taek Yim OTH (45)
- Ju Yin Kim OTH (46)
- Jung Gi Hong DRC (27)
- Sun Jik Hong DRC (70)
- Pan Sik Jang NID (51)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 27th, 1994
- Public Since
- December 26th, 2007
- No. of Shareholders
- 33,566
- No. of Employees
- 37
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ
- Shares in Issue
- 41,676,758

- Address
- 1075-1 Sangpaedong, DONGDUCHEON, 11341
- Web
- http://www.1sbb.com/
- Phone
- +82 318671384
- Auditors
- Echon Accounting Corp.
Upcoming Events for 068330
Similar to 068330
Access Bio
Korea Exchange - KOSDAQ
Aligned Genetics
Korea Exchange - KOSDAQ
Alphanox Co
Korea Exchange - KOSDAQ
Angel Robotics Co
Korea Exchange - KOSDAQ
Asta Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 21:14 UTC, shares in Ilshinbiobase Co are trading at KR₩1,044. This share price information is delayed by 15 minutes.
Shares in Ilshinbiobase Co last closed at KR₩1,044 and the price had moved by -21.87% over the past 365 days. In terms of relative price strength the Ilshinbiobase Co share price has underperformed the FTSE Developed Asia Pacific Index by -20.98% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Ilshinbiobase Co dividend yield is 0.67% based on the trailing twelve month period.
Last year, Ilshinbiobase Co paid a total dividend of KR₩7, and it currently has a trailing dividend yield of 0.67%. We do not have any data on when Ilshinbiobase Co is to next pay dividends.
We do not have data on when Ilshinbiobase Co is to next pay dividends. The historic dividend yield on Ilshinbiobase Co shares is currently 0.67%.
To buy shares in Ilshinbiobase Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩1,044, shares in Ilshinbiobase Co had a market capitalisation of KR₩44bn.
Here are the trading details for Ilshinbiobase Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 068330
Based on an overall assessment of its quality, value and momentum Ilshinbiobase Co is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ilshinbiobase Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -7.9%.
As of the last closing price of KR₩1,044, shares in Ilshinbiobase Co were trading -11.56% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ilshinbiobase Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩1,044.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ilshinbiobase Co's management team is headed by:
- Seong Dae Hong - CEO
- Jae Yong Kim - OTH
- Bang Taek Yim - OTH
- Ju Yin Kim - OTH
- Jung Gi Hong - DRC
- Sun Jik Hong - DRC
- Pan Sik Jang - NID